Home » Topics » BioWorld Science

BioWorld Science
RSS

Oral insulin sensitizer RWJ-241947/MCC-555 tested in animal models of type 2 diabetes

Sep. 13, 2001

Danish investigators report clinical results for stevioside in diabetes at EASD

Sep. 13, 2001

Corixa and GSK complete resubmission of Bexxar BLA to FDA

Sep. 13, 2001

Interneuron initiates U.S. phase III clinical trial with trospium for overactive bladder

Sep. 13, 2001

Selective iNOS inhibitor protects against IL-1beta-induced rat pancreatic islet damage

Sep. 13, 2001

Poliovirus-based HIV vaccine in development at Iguazu

Sep. 13, 2001

GSK3 inhibitor CT-98023 targets glucose intolerance and insulin resistance of type 2 diabetes

Sep. 13, 2001

Further submissions announced for Visudyne

Sep. 13, 2001

LJP files IND for second clinical candidate

Sep. 13, 2001

New platinum compound licensed by NeoOncoRx, heading for phase III

Sep. 13, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.